This is a preview of subscription content, log in via an institution to check access.
Reference
Havers FP, et al. Economic impact of implementing decennial tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccination in adults in the United States. Vaccine : 31 Oct 2019. Available from: URL: https://doi.org/10.1016/j.vaccine.2019.09.104
Rights and permissions
About this article
Cite this article
DTaP booster not cost effective unless pertussis incidence high. PharmacoEcon Outcomes News 841, 17 (2019). https://doi.org/10.1007/s40274-019-6369-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-019-6369-5